| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 02/13/2001 | CA2021788C Cyclosporin derivatives |
| 02/08/2001 | WO2001009191A1 Computational design methods for making molecular mimetics |
| 02/08/2001 | WO2001009171A1 Novel tachykinin peptides, precursor peptides thereof and genes encoding the same |
| 02/08/2001 | WO2001008792A2 Charged filtration membranes and uses therefor |
| 02/08/2001 | WO2000069894A3 Novel indications of mannan-binding lectin (mbl) in the treatment of immunocompromised individuals |
| 02/08/2001 | CA2380354A1 Novel tachykinin peptides, precursor peptides thereof and genes encoding the same |
| 02/08/2001 | CA2379413A1 Charged filtration membranes and uses therefor |
| 02/08/2001 | CA2377244A1 Computational design methods for making molecular mimetics |
| 02/07/2001 | EP1074559A1 Peptide nucleic acids |
| 02/07/2001 | EP1073899A1 Improved method for purifying cholera toxin |
| 02/07/2001 | EP1073891A2 Method of prediciting receptor modulating activity |
| 02/07/2001 | EP1073763A1 Methods for transducing fusion molecules |
| 02/07/2001 | EP1073750A1 Preparation of human papillomavirus e1 having helicase activity and method therefor |
| 02/07/2001 | EP1073668A2 Solution phase biopolymer synthesis |
| 02/07/2001 | EP1073457A1 Modifications of antigens by the introduction of aldehyde groups and their use in enhancing the immune response |
| 02/07/2001 | EP0562025B1 Compounds and their use in a binary synthesis strategy |
| 02/07/2001 | CN1061685C Regenerated silk protein and complex material thereof for fixation of onzyme and bio-active substance |
| 02/06/2001 | US6184360 Purification of NGF |
| 02/06/2001 | US6184344 Synthesis of proteins by native chemical ligation |
| 02/06/2001 | US6184207 A peptide including specified piperidine-containing group, having an n-terminal hydrophobic residue and optionally an amidated c-terminal of specified end groups; treating multiple sclerosis or rheumatoid arthritis |
| 02/06/2001 | US6183949 HCV peptide antigens and methods for the determination of HCV |
| 02/06/2001 | US6183759 Acylated peptide or a salt thereof obtainable by condensing a hydrolysed protein-derived peptide with a lanolin-derived non-hydroxyl fatty acid containing iso-type fatty acids |
| 02/06/2001 | CA2172144C Hapten-marked peptides |
| 02/06/2001 | CA2125467C Process for producing hydrophobic polypeptides, proteins or peptides |
| 02/06/2001 | CA2106612C Displacement chromatography process |
| 02/06/2001 | CA2106299C Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 02/06/2001 | CA2067744C The human c3b/c4b receptor (cr1) |
| 02/01/2001 | WO2001007657A1 Peptide acceptor ligation methods |
| 02/01/2001 | WO2001007469A2 Polypeptide dendrimers as unimolecular carriers of diagnostic imaging contrast agents, bioactive substances and drugs |
| 02/01/2001 | WO2001007451A2 Isolation of biomolecules |
| 02/01/2001 | WO2000063248A3 Highly purified gonadotropin compositions and process for preparing them |
| 02/01/2001 | WO2000062034A3 Multistage electromagnetic separator for purifying cells, chemicals and protein structures |
| 02/01/2001 | WO2000021658A3 Porous device |
| 02/01/2001 | DE10031839A1 Erythropoietinkonjugate Erythropoietinkonjugate |
| 02/01/2001 | CA2693274A1 Peptide acceptor ligation methods |
| 02/01/2001 | CA2380178A1 Polypeptide dendrimers as unimolecular carriers of diagnostic imaging contrast agents, bioactive substances and drugs |
| 01/31/2001 | EP1071958A1 Methods for substrate-ligand interaction screening |
| 01/31/2001 | EP1071955A1 Improved immunodiagnostic assays using reducing agents |
| 01/31/2001 | EP1071716A1 Process for concentrating protein with disease-related conformation |
| 01/31/2001 | EP1071711A1 Process for the recovery and purification of a recombinant protein from a cell |
| 01/31/2001 | EP1071705A2 Peptides causing formation of compact structures |
| 01/31/2001 | EP1071703A1 NOVEL PROCESS FOR THE SEPARATION OF PROTEINS USING A Ca++ CONTAINING ELUANT |
| 01/31/2001 | EP1071451A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 01/31/2001 | EP0920528A4 Synthetic protein folding catalysis |
| 01/31/2001 | CN1282367A Granule with hydrated barrier material |
| 01/31/2001 | CN1282339A Monoclonal antibody to alpha 2-macroglobulin and its use for detecting glucan |
| 01/31/2001 | CN1282271A Method and apparatus for chemical synthesis |
| 01/30/2001 | US6180761 Casein from Korean cattle |
| 01/30/2001 | US6180759 Process for the preparation of azacycloalkylakanoyl pseudotetrapeptides |
| 01/30/2001 | US6180757 Process for the separation of proteins using a CA++ containing eluant |
| 01/30/2001 | US6180370 Preparing preferential antibodies; generating nucleotide sequences coding preferential antibodies, expressing nucleotide sequences in transformed cell and recovering preferential antibodies |
| 01/30/2001 | US6180336 Labelling and selection of molecules |
| 01/30/2001 | US6180140 Modified amino acids for drug delivery |
| 01/30/2001 | CA2139931C Purification of factor ix |
| 01/30/2001 | CA2064558C Method for inhibiting growth of stem cells |
| 01/25/2001 | WO2001006496A1 Inorganic permeation layer for micro-electric device |
| 01/25/2001 | WO2001005995A1 Method of preparing cell cultivation supernatant |
| 01/25/2001 | WO2001005808A2 In vitro selection and optional identification of polypeptides using solid support carriers |
| 01/25/2001 | WO2001005757A2 Process for the deprotection of protected thiols |
| 01/25/2001 | CA2379762A1 Inorganic permeation layer for micro-electric device |
| 01/25/2001 | CA2379143A1 In vitro selection and optional identification of polypeptides using solid support carriers |
| 01/24/2001 | EP1070085A1 DUAL A v?b 3? AND METASTASIS-ASSOCIATED RECEPTOR LIGANDS |
| 01/24/2001 | EP1070080A1 HUMAN EDG-1c POLYNUCLEOTIDES AND POLYPEPTIDES AND METHODS OF USE |
| 01/24/2001 | EP0676964B1 Nitrosylation of enzyme sh groups as a therapeutic modality |
| 01/24/2001 | EP0630260B1 Polysaccharide-protein conjugates |
| 01/24/2001 | CN1281467A Crystalline teriparatide |
| 01/24/2001 | CN1281346A Novel fluorescent reporter molecules and their applications, including assays for caspases |
| 01/24/2001 | CN1280833A Process for preparing multi-strain antibody from waterfowls |
| 01/23/2001 | US6177558 During solid phase synthesis of nucleic acids, peptides and peptide nucleic acids on an open environment solid support, the polar aprotic solvent selected from mono- and dinitriles, glymes, diglymes, triglymes, and trimethylphosphates |
| 01/23/2001 | US6177550 Process for extraction of a growth factor complex |
| 01/23/2001 | US6177548 Enhanced aggregate removal from bulk biologicals using ion exchange chromatography |
| 01/23/2001 | US6176962 Methods for fabricating enclosed microchannel structures |
| 01/23/2001 | CA2296884C Targeted liposomes and methods for liposome-protein coupling |
| 01/23/2001 | CA2221767C A peptide inhibiting elevations of triglyceride levels in blood and an agent for inhibiting elevations of triglyceride levels in blood comprising the peptide as an active component |
| 01/18/2001 | WO2001004287A1 A method for preparing modified polypeptides |
| 01/18/2001 | WO2001004265A2 C-terminal protein tagging |
| 01/18/2001 | WO2001004154A1 Method for purifying granulocyte colony stimulating factor |
| 01/18/2001 | DE19930676A1 Verfahren zur Stabilisierung von Proteinen in komplexen Mischungen bei deren Lagerung in wäßrigen Lösungsmitteln A process for the stabilization of proteins in complex mixtures with storage thereof in aqueous solvents |
| 01/18/2001 | CA2680437A1 Peptides that lower blood glucose levels |
| 01/18/2001 | CA2378566A1 Method for purifying granulocyte colony stimulating factor |
| 01/18/2001 | CA2372795A1 C-terminal protein tagging |
| 01/17/2001 | EP1069131A1 Methods for separating particulate substrates from solution while minimizing particle loss |
| 01/17/2001 | EP1068522A1 Antigen |
| 01/17/2001 | EP1068240A1 Method for sterilising native collagen in liquid medium, resulting native collagen, compositions containing same and uses |
| 01/17/2001 | EP1068221A2 Template associated npy y2-receptor agonists |
| 01/17/2001 | EP0856008B1 Method of separating albumin from serum by ion-exchange chromatography with membrane adsorbers |
| 01/17/2001 | EP0640135B1 Immunoglobulin binding proteins derived from l protein and their uses |
| 01/17/2001 | CN1280586A Erythropoietin with high specific activity |
| 01/17/2001 | CN1280196A Production method for saccharide including using transglutaminase treating cereal powder material |
| 01/17/2001 | CN1280137A Erythrocyte-stimulating factor coupling |
| 01/17/2001 | CN1280134A Technology for preparing soildifying metal ion-affine chromatograply glue |
| 01/16/2001 | US6174704 Use of an aqueous reagent solution consisting essentially of an alkylglycoside or alkythioglycoside to lyse the cell and concurrent therewith to extract the protein of interest from other host cellular components |
| 01/16/2001 | US6174700 Purification of a polypeptide compound having a polysaccharide binding domain by affinity phase separation |
| 01/16/2001 | US6174692 Detecting preferential antigen in sample; incubating monoclonal antibody with sample containing preferential antigen and detecting biinding |
| 01/16/2001 | US6174691 Deactivating a preferential tumor glycoprotein or a cell expressing preferential glycoprotein; exposing preferential glycoprotein or cell expressing the preferential glycoprotein to a toxic substance |
| 01/16/2001 | US6174530 Homogeneous polyoxime compositions and their preparation by parallel assembly |
| 01/16/2001 | CA2204355C Peripheral nervous system specific sodium channels, dna encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 01/16/2001 | CA2188793C Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof |
| 01/16/2001 | CA2010800C Protein labelling |
| 01/11/2001 | WO2001002435A1 Method for stabilising proteins in complex mixtures during their storage in aqueous solvents |